Market Research Life Sciences Market Research Biotechnology Market Research Stem Cell Market Research

Automated & Closed Cell Therapy Processing Systems Market by Workflow (Apheresis, Cryopreservation, Expansion), Type (Non-Stem Cell Therapy, Stem Cell Therapy), Scale - Global Forecast 2024-2030

Best Price Guarantee Length Publisher Published Date SKU
from $4,749 186 Pages 360iResearch January, 2024 IRE18418646
Best Price Guarantee
Price from $4,749
Length 186 Pages
Publisher 360iResearch
Published Date January, 2024
SKU IRE18418646

Automated & Closed Cell Therapy Processing Systems Market by Workflow (Apheresis, Cryopreservation, Expansion), Type (Non-Stem Cell Therapy, Stem Cell Therapy), Scale - Global Forecast 2024-2030


The Automated & Closed Cell Therapy Processing Systems Market size was estimated at USD 943.94 million in 2023 and expected to reach USD 1,087.97 million in 2024, at a CAGR 15.74% to reach USD 2,626.76 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Automated & Closed Cell Therapy Processing Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Automated & Closed Cell Therapy Processing Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Automated & Closed Cell Therapy Processing Systems Market, highlighting leading vendors and their innovative profiles. These include Bio-Techne Corporation, BioLife Solutions Inc., BioSpherix, Ltd., Cellares Inc., Corning Incorporated, Cytiva, Danaher Corporation, Fresenius SE & Co. KGaA, General Electric Company, Lonza Group AG, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novartis AG, Pluristem Therapeutics Inc., Regeneus Ltd., Sartorius AG, STEMCELL Technologies Canada Inc., Terumo Corporation, Thermo Fisher Scientific, Inc., and Thermogenesis Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Automated & Closed Cell Therapy Processing Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

Workflow

Apheresis
  • Cryopreservation
  • Expansion
  • Fill- Finish
  • Separation
  • Type

    Non-Stem Cell Therapy
  • Stem Cell Therapy
  • Scale

    Commercial Scale
  • Pre-commercial or R&D Scale
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Automated & Closed Cell Therapy Processing Systems Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Automated & Closed Cell Therapy Processing Systems Market?
    3. What are the technology trends and regulatory frameworks in the Automated & Closed Cell Therapy Processing Systems Market?
    4. What is the market share of the leading vendors in the Automated & Closed Cell Therapy Processing Systems Market?
    5. Which modes and strategic moves are suitable for entering the Automated & Closed Cell Therapy Processing Systems Market?


    Note: PDF & Excel + Online Access - 1 Year


    • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Automated & Closed Cell Therapy Processing Systems Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Rising popularity of regenerative medicines & cell therapies
    5.1.1.2. Growing need for cost-effective and personalized drugs
    5.1.1.3. Operational superiority of automated systems over manual processing
    5.1.2. Restraints
    5.1.2.1. Biological variations associated with different therapies
    5.1.3. Opportunities
    5.1.3.1. Advancing research and development activities in automated cell therapy processing systems
    5.1.3.2. Integration of advanced therapy development procedures and software technologies
    5.1.4. Challenges
    5.1.4.1. Lack of skilled professionals and complicated process of automation
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Automated & Closed Cell Therapy Processing Systems Market, by Workflow
    6.1. Introduction
    6.2. Apheresis
    6.3. Cryopreservation
    6.4. Expansion
    6.5. Fill- Finish
    6.6. Separation
    7. Automated & Closed Cell Therapy Processing Systems Market, by Type
    7.1. Introduction
    7.2. Non-Stem Cell Therapy
    7.3. Stem Cell Therapy
    8. Automated & Closed Cell Therapy Processing Systems Market, by Scale
    8.1. Introduction
    8.2. Commercial Scale
    8.3. Pre-commercial or R&D Scale
    9. Americas Automated & Closed Cell Therapy Processing Systems Market
    9.1. Introduction
    9.2. Argentina
    9.3. Brazil
    9.4. Canada
    9.5. Mexico
    9.6. United States
    10. Asia-Pacific Automated & Closed Cell Therapy Processing Systems Market
    10.1. Introduction
    10.2. Australia
    10.3. China
    10.4. India
    10.5. Indonesia
    10.6. Japan
    10.7. Malaysia
    10.8. Philippines
    10.9. Singapore
    10.10. South Korea
    10.11. Taiwan
    10.12. Thailand
    10.13. Vietnam
    11. Europe, Middle East & Africa Automated & Closed Cell Therapy Processing Systems Market
    11.1. Introduction
    11.2. Denmark
    11.3. Egypt
    11.4. Finland
    11.5. France
    11.6. Germany
    11.7. Israel
    11.8. Italy
    11.9. Netherlands
    11.10. Nigeria
    11.11. Norway
    11.12. Poland
    11.13. Qatar
    11.14. Russia
    11.15. Saudi Arabia
    11.16. South Africa
    11.17. Spain
    11.18. Sweden
    11.19. Switzerland
    11.20. Turkey
    11.21. United Arab Emirates
    11.22. United Kingdom
    12. Competitive Landscape
    12.1. FPNV Positioning Matrix
    12.2. Market Share Analysis, By Key Player
    12.3. Competitive Scenario Analysis, By Key Player
    13. Competitive Portfolio
    13.1. Key Company Profiles
    13.1.1. Bio-Techne Corporation
    13.1.2. BioLife Solutions Inc.
    13.1.3. BioSpherix, Ltd.
    13.1.4. Cellares Inc.
    13.1.5. Corning Incorporated
    13.1.6. Cytiva
    13.1.7. Danaher Corporation
    13.1.8. Fresenius SE & Co. KGaA
    13.1.9. General Electric Company
    13.1.10. Lonza Group AG
    13.1.11. Merck KGaA
    13.1.12. Miltenyi Biotec B.V. & Co. KG
    13.1.13. Novartis AG
    13.1.14. Pluristem Therapeutics Inc.
    13.1.15. Regeneus Ltd.
    13.1.16. Sartorius AG
    13.1.17. STEMCELL Technologies Canada Inc.
    13.1.18. Terumo Corporation
    13.1.19. Thermo Fisher Scientific, Inc.
    13.1.20. Thermogenesis Holdings, Inc.
    13.2. Key Product Portfolio
    14. Appendix
    14.1. Discussion Guide
    14.2. License & Pricing
    FIGURE 1. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET RESEARCH PROCESS
    FIGURE 2. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2023 VS 2030
    FIGURE 3. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET DYNAMICS
    FIGURE 7. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
    FIGURE 8. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
    FIGURE 10. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2023 VS 2030 (%)
    FIGURE 12. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 14. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 16. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 22. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023

    $4,749
    $5,749
    $6,749
    $8,749

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings